Recent breakthroughs in the field of obesity treatment have presented a new candidate known as ALLUVI Retatrutide. This medication is a {highlyeffective GLP-1 receptor agonist, formulated to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown significant outcomes in clinical trials, exhibiting significant losses in body